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ABSTRACT
In Trypanosoma brucei, DNA recombination is crucial
in antigenic variation, a strategy for evading the mam-
malian host immune system found in a wide variety
of pathogens. T.brucei has the capacity to encode
.1000 antigenically distinct variant surface glycopro-
teins (VSGs). By ensuring that only one VSG is
expressed on the cell surface at one time, and by peri-
odically switching the VSG gene that is expressed,
T.brucei can evade immune killing for prolonged peri-
ods. Much of VSG switching appears to rely on a
widely conserved DNA repair pathway called homo-
logous recombination, driven by RAD51. Here, we
demonstrate that T.brucei encodes a further five
RAD51-related proteins, more than has been identi-
fied in other single-celled eukaryotes to date. We have
investigated the roles of two of the RAD51-related pro-
teins in T.brucei, andshow that theycontribute toDNA
repair, homologous recombination and RAD51 func-
tion in the cell. Surprisingly, however, only one of the
two proteins contributes to VSG switching, suggest-
ing that the family of diverged RAD51 proteins present
in T.brucei have assumed specialized functions in
homologous recombination, analogous to related
proteins in metazoan eukaryotes.
INTRODUCTION
DNA recombination is central to the survival and functioning
of all organisms. Recombination is one of a number of DNA
repair pathways that reverse genotoxic damage (1), it is intim-
ately linked to DNA replication (2,3), it can provide a means
for telomere maintenance (4) and is crucial in genetic exchange
(5). Some organisms harness recombination reactions for spe-
cific genetic functions; prominent examples include vertebrate
immunoglobulin and T-cell receptor gene re-arrangements (6),
and mating type gene switching in fungi (7). In pathogenic
organisms, including bacteria, fungi and protozoans,
recombination can be central to strategies for dealing with
host immunity (8,9). African trypanosomes, including
Trypanosoma brucei, are protistan parasites of mammals
belonging to a deeply branching eukaryotic order termed
the kinetoplastida (10), and are responsible for devastating
disease in sub-Saharan Africa. T.brucei is an exclusively extra-
cellular parasite of the mammalian bloodstream and tissue
fluids, and is subject to immune attack throughout an infection.
To avoid being eliminated by the immune response, T.brucei
uses antigenic variation of its major surface antigen, the vari-
ant surface glycoprotein (VSG). Related strategies of antigenic
variation have evolved in a diverse range of pathogens (11).
In T.brucei each cell expresses one antigenic form of VSG
at one time and switches this to another VSG during antigenic
variation [for recent reviews see (12–14)]. Switching of the
expressed VSG gene is not elicited by the host immune
response and can occur by two mechanisms, which are con-
sidered to be distinct. To ensure expression of a single VSG
coat, VSG genes are transcribed only when present in a telo-
meric transcription unit termed the expression site (ES)
(15,16). Because T.brucei contains 20 mammalian ESs, a
VSG switch can be effected by silencing the actively tran-
scribed ES and activating one of the silent ESs (17,18). The
mechanisms and factors which control this transcriptional, or
in situ, switching reaction are not understood. However, it
appears to be a co-ordinated process (19), and the active
ES is found in a sub-nuclear domain, termed the ES body
(20,21), from which the inactive ESs appear to be excluded.
Outside the ESs, the T.brucei genome contains >1000 VSG
genes (22), which are transcriptionally silent in situ, but can be
activated by recombination into the ESs. A number of such
recombination reactions have been described. The most com-
monly observed are gene conversions, where a copy is gen-
erated from a silent VSG and displaces the VSG resident in the
ES (23,24). Less commonly observed are crossover, or reci-
procal, recombination reactions where chromosome ends, con-
taining the active ES and a silent VSG, are exchanged (25,26).
Finally, segmental gene conversion reactions have also been
described where novel VSG genes are constructed from the
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open reading frames (ORFs) of multiple silent VSGs or VSG
pseudogenes (27–29).
In contrast to transcriptional switching, an understanding of
the factors that contribute to VSG switching by recombination
is now emerging. Mutation of the T.brucei gene encoding
RAD51, the eukaryotic enzyme that catalyses DNA strand
exchange during homologous recombination (30), reduces
the frequency of VSG switching (31). In contrast, mutation
of KU70 or KU80, which together act as a heterodimer in other
eukaryotes to co-ordinate a distinct form of DNA double-
strand break (DSB) repair termed non-homologous end-
joining (32), does not affect the frequency of VSG switching
(33). These data imply that at least some of the reactions that
contribute to T.brucei antigenic variation utilize homologous
recombination. However, detailed analysis of the VSG switch-
ing mechanisms used in RAD51 mutants suggests this may not
represent the whole picture. First, VSG switching by gene
conversion (31), and other forms of recombination (34), can
be detected in T.brucei RAD51 mutants, although at a reduced
level. This suggests that RAD51-independent recombination
pathways operate in T.brucei and can act in VSG switching.
Second, the reduced VSG switching frequency in RAD51
mutants appears, surprisingly, to involve a reduction in both
gene conversion and transcriptional switching reactions, des-
pite a lack of evidence that the latter mechanism involves
recombination. More recent work has also suggested that
the link between VSG switching and homologous recombina-
tion may not be straightforward. T.brucei MRE11 mutants are
impaired comparably with RAD51 mutants in homologous
recombination and display elevated levels of chromosomal
re-arrangements (35,36), phenotypes consistent with T.brucei
MRE11 either catalysing or regulating recombination in sim-
ilar ways to other eukaryotes (37). Despite this, we found no
evidence that MRE11 acts in VSG switching (35). We have
also characterized the genes that act in mismatch repair
(MMR) in T.brucei, and show that this DNA repair process,
as in other organisms, influences homologous recombination
(38,39). However, like MRE11, we found no evidence that
MMR influences VSG switching.
To assess more directly the role of RAD51 and homologous
recombination in VSG switching, this work has examined the
functions of two genes putatively more intimately linked to
RAD51 function than either MRE11 or MMR. Although Rad51
and its eubacterial homologue, RecA can alone catalyse
homology-directed DNA strand exchange in vitro, other fac-
tors are needed in vivo (40,41). Prominent amongst these are
multiple Rad51-like proteins encoded by most eukaryotes. A
meiosis-specific protein named Dmc1 has been described in
many, but not all, eukaryotes and is highly related to Rad51 in
both sequence and function (42,43). Variable numbers of more
distantly related Rad51-like proteins, often called Rad51 para-
logues (44,45), are found in most eukaryotes. Saccharomyces
cerevisiae contains two such Rad51-like proteins, Rad55 and
Rad57 (46). These are found also in Schizosaccharomyces
pombe (which may have a further Rad51 paralogue, Rlp1)
(47), whereas another fungus, Ustilago maydis, encodes a
single, highly diverged Rad51 paralogue, Rec2 (48). Verteb-
rates, plants and insects encode an expanded repertoire of
Rad51-like factors relative to fungi. Five Rad51 paralogues
have been described in vertebrates (44) and in Arabidopsis
thaliana (49), and are named Xrcc2, Xrcc3, Rad51B
(Rad51L1), Rad51C (Rad51L2) and Rad51D (Rad51L3).
Drosophila, in contrast, encodes a subtly distinct repertoire
of Rad51-like proteins: Rad51 (named SpnA) and four RAD51
paralogues (SpnB, SpnD, Rad51C and Rad51D) have been
described, but Dmc1 is absent (50,51).
The roles of the Rad51 paralogues have been best charac-
terized to date in yeast and vertebrates. Mutants of yeast Rad55
and Rad57 display cold-dependent DNA damage sensitivity,
impaired recombination (52,53) and a defect in Rad51 sub-
nuclear localization during DSB repair that is most marked
during meiosis (54–56). Mutations of most vertebrate Rad51
paralogues are embryonically lethal (57–59), but mitotic
repair, recombination and Rad51 localization defects have
been described in mutants of vertebrate cell lines (60–66),
which also display chromosome instability (58,67). in vitro
and in vivo studies suggest that yeast Rad55 and Rad57 form a
stable heterodimer (52,68) that mediates the formation of, or
stabilizes, Rad51 nucleoprotein filaments on single-stranded
DNA (69,70). In contrast, the vertebrate Rad51 paralogues
form two complexes, one composed of Xrcc3 and Rad51C,
and the other composed of Rad51B, Rad51C, Rad51D and
Xrcc2 (71–74). In vitro assays suggest that at least some ver-
tebrate Rad51-like proteins can act as mediators of Rad51
DNA strand exchange (75–77), analogous to yeast Rad55–
Rad57. However, considerable work suggests that they may
play roles beyond this (Discussion), adopting discrete roles at
either early (78) or late (79,80) steps in homologous recomb-
ination, or at discrete regions of the genome (81). Whether or
not vertebrate Rad51-like functions, and sub-cellular com-
plexes, are conserved in Arabidopsis and Drosophila is not
yet clear. Mutations in four of the Arabidopsis Rad51 para-
logues are developmentally viable but result in increased sens-
itivity to DNA cross-linking agents (49,82,83). In Drosophila,
SpnB mutants display modestly increased sensitivity to ion-
izing radiation (50). During meiosis, discrete functions of the
proteins are apparent in both organisms. In Arabidopsis, muta-
tions in Rad51C and Xrcc3, though not Rad51B or Xrcc2,
impair meiosis (49,82,83). Indeed, Drosophila SpnD may
be truly meiosis-specific, since mutants are impaired in mei-
osis but do not display detectably increased sensitivity to DNA
damage (84,85).
Here, we show that T.brucei encodes a repertoire of
RAD51-like proteins more similar to metazoans than to
fungi. Mutations in two of the proteins resulted in reduced
levels of recombination, altered the sub-nuclear localization of
RAD51 following DNA damage and sensitized the parasite to
induced DNA damage. Surprisingly, only one of the two pro-
teins contributes to antigenic variation, suggesting distinct
functions of the T.brucei RAD51 paralogues in homologous
recombination.
MATERIALS AND METHODS
Trypanosoma brucei strains, growth and transformation
T.brucei bloodstream cells of strain 3174, a derivative of
MITat1.2a (86), were used throughout and grown at 37C
in HMI-9 medium (87). Growth rates in vitro were determined
by diluting the T.brucei cell lines to 5 · 104 cells ml1 and
counting concentrations thereafter with a haemocytometer
(bright-line; Sigma); in vivo growth rates were assayed as
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described previously (31). Electroporation of DNA constructs
was conducted as described previously (34,38). In generating
RAD51-3 mutants, transformants were selected with 0.5 or
1.0 mg ml1 puromycin and 2.5 mg ml1 blasticidin, while
RAD51-5 mutants were selected with 0.25 mg ml1 puromycin
and 2.5 mg ml1 blasticidin. To assay recombination, 5 · 107
cells of each T.brucei cell line, grown to a maximum density
of 2 · 106 cells ml1, were transformed with 5 mg of tub-
BLE-tub (pRM450) that had been digested with NotI and
ApaI. Electroporated cells were recovered in non-selective
media for three generations (24 h for wild-type and +/
mutants; 45 and 39 h for the rad51-3/ and rad51-5/
mutants, respectively) before applying selection with
2 mg ml1 phleomycin. For wild-type and +/ cells,
5 · 106 electroporated cells were plated over 24 wells in
1.5 ml well1 of antibiotic selective media. In contrast,
2 · 107 cells were plated over 48 wells for the rad51-3/
and rad51-5/ mutants. Three independent transformations
were performed for each cell line.
Generation and analysis of RAD51-3 and
RAD51-5 mutants and re-expressors
Constructs for gene disruption contained expression cassettes
for puromycin N-acetyl transferase (puromycin) or blasticidin
S deaminase (blasticidin) flanked by 50 and 30 sequences
derived from the RAD51-3 or RAD51-5 ORFs and were
used over two successive rounds of transformation to disrupt
both alleles of the two genes. For RAD51-3, the 50 flank was
336 bp of sequence beginning 9 bp downstream of the pre-
dicted start codon and was PCR-amplified from MITat1.2
genomic DNA using Herculase DNA polymerase (Stratagene)
with the primers RAD57-LHF-For (50-GATACACTA-
GAATTCCAATGCTCCTCACTTACCCC; EcoRI under-
lined) and RAD57-LHR-Rev (50-GGTAAGCTTGTTAAC-
AAGAATATCAAGACTCCGGC; HindIII, HpaI underlined);
the 30 flank was 368 bp, ending 3 bp upstream of the stop
codon, and was amplified with RAD57-RHF-For (50-ACA-
AAGCTTGATATCCAAATGGCACACGTATGGGG; Hind-
III, EcoRV underlined) and RAD57-RHF-Rev (50-ACTGG-
CAGACTCGAGAGTGGGTCGGAAAACATCGC; XhoI
underlined). For RAD51-5, the 50 flank was 200 bp of sequence
beginning immediately downstream of the start codon and was
PCR-amplified with RECA-LHF-For (50-GATACACTA-
GAATTCATGTCTGTGTGTCCTCCACC; EcoRI under-
lined) and RECA-LHR-Rev (50-GGTAAGCTTGTTAACA-
ACACCTCCAGGACTGTCCC; HindIII, HpaI underlined);
the 30 flank was 225 bp, ending 65 bp upstream of the stop
codon, and was amplified with RECA-RHF-For (50-ACAAA-
GCTTGATATCTCTGTTGGTGGTAGTGTGGC; HindIII,
EcoRV underlined) and RECA-RHF-Rev (50-ACTGGCA-
GACTCGAGATACG TGTTTTGCAG CCCCG; XhoI
underlined). For each gene, the 50 and 30 flanks were cloned
together into EcoRI–XhoI digested pBluescript (Stratagene).
Gene disruption constructs were then made by cloning blasti-
cidin (BSD) or puromycin (PUR) resistance cassettes into
the HpaI sites between the two flanks, generating the con-
structs RAD51-3::BSD or RAD51-5::BSD, and RAD51-
3::PUR or RAD51-5::PUR, respectively; the resistance cas-
settes consisted of the antibiotic resistance ORF flanked by
processing sequences derived from actin or tubulin intergenic
sequences. All the gene disruption constructs were digested
with NotI and ApaI before transformation.
Re-expression of RAD51-3 and RAD51-5 in their respective
/ mutants was performed by PCR amplifying the genes’
ORFs with Herculase polymerase and cloning them into
EcoRV-digested construct pRM481. Here, the genes were
flanked upstream by, successively, a 400 bp actin intergenic
sequence and a phleomycin resistance gene (BLE). Surround-
ing these sequences were targeting flanks that allowed
RAD51-3 and RAD51-5 to be integrated, following trans-
formation of the pRM481-derived constructs, into the tubulin
array, replacing an a-tubulin ORF. In this location, expression
of the genes relies on read-through transcription and mRNA
processing by the pRM481-derived upstream actin sequence
and downstream b-tubulin sequence. Integration of RAD51-3
and RAD51-5 into the tubulin locus was confirmed by South-
ern analysis of transformant genomic DNA digested with
BstXI or SpeI, respectively.
Drug resistant transformants were analysed by probing
Southern blots of restriction digested genomic DNA that
had been separated on 0.8% agarose gels using a-32P radiola-
belled DNA fragments. For RT–PCR, total RNA was prepared
from T.brucei cell lines using an RNeasy kit (Qiagen) and
cDNA was synthesized with random hexamers and Super-
script reverse transcriptase (Life Technologies). For
RAD51-3, the primers RAD57-KO50 (50-TGTAACAA-
CACTTTGCCG) and RAD57-KO30 (50-CCGTGACTTT-
CAATAACGCC) were used, giving a product of 669 bp if
intact RNA is present; for RAD51-5, primers RECA- LHF-For
and RECA-U2 (50-GGGATTGAGAGAGGACGGG) were
used, giving a 435 bp product on intact RNA. RNA
Polymerase (Pol) I control primers have been described
before (26).
Assaying DNA damage sensitivity and
VSG switching frequency
Sensitivities of the T.brucei cell lines to methyl methanesulph-
onate (MMS) were assayed essentially as described before
(33,35). Cells were grown to a maximum density of
1 · 106 cells ml1, and plated in 96-well plates at a concen-
tration of 1 cell well1 in increasing concentrations of
MMS, plus a no drug control. For each cell line, at each
drug concentration, four repetitions were performed. The num-
bers of wells with viable parasite populations were scored
initially after 7 days, and monitored for further growth up
to 20 days.
Determination of VSG switching frequency was performed
as described before (31,86), but with some modifications. To
allow VSG switched variants to arise, all cell lines were
diluted from media containing hygromycin (5 mg ml1) and
G418 (2.5 mg ml1) into non-selective media at a starting
concentration of 4 · 104 cells ml1. The cells were then
grown for nine generations, taking into account the increased
generation times of the / mutants, before injection into
immunized mice. For the wild-type and +/ mutants
4 · 107 cells were injected, whereas 8 · 107 / mutant
cells were injected. Switched variants were recovered in all
cases 24 h later, and VSG switching frequency calculations
take account of the smaller numbers of divisions the /
mutants undergo in this time.
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RAD51 immunolocalization
To examine the localization of RAD51 following DNA dam-
age, 5 ml cultures of the cell lines were inoculated at 106 cells
ml1 in media containing phleomycin. After 18 h growth,
1.5 ml was centrifuged at 1500 g for 10 min at room temper-
ature, resuspended in 1 ml of phosphate-buffered saline (PBS,
pH 7.4), centrifuged again and resuspended in 40 ml of PBS.
Samples (20 ml) were allowed to settle on glass slides, air-dried
and soaked in methanol for 10 min at room temperature. The
slides were then washed in PBS containing 0.2% Tween-20 for
5 min and placed in a humid chamber. Polyclonal antiserum
(1 ml), raised in lop-eared rabbits (Diagnostics Scotland, UK)
against bacterially expressed, histidine-tagged T.brucei
RAD51 and diluted 1:500 in PBS containing 1% Tween-20
and 3% BSA (PBS-T-BSA), was added to each slide for 90 min
at room temperature. The slides were rinsed with PBS-T-BSA,
soaked twice in fresh PBS-T-BSA for 5 min, then returned to
the humid chamber, where 0.5 ml of the fluorescein isothiocy-
anate (FITC) conjugated goat-derived anti-rabbit IgG (Sigma),
diluted 1:100 in PBS-T-BSA, was added for 30 min at room
temperature. The slides were then rinsed with PBS-T-BSA,
again soaked twice in PBS-T for 5 min, before being mounted
in Vectashield with 4,6-diamidino-2-phenylindole (DAPI;
Vector laboratories). Microscopic analysis was performed
using an Axioskop 2 microscope (Zeiss) and images obtained
with Openlab software (Improvision). Two researchers
scored independently 100–120 cells for the presence and num-
ber of visible sub-nuclear foci.
Accession numbers of kinetoplastid RAD51-related
proteins analysed in this study
T.brucei RAD51: XP_828893/AAD51713. T.cruzi RAD51:
XP_814843/AAZ94621. L.major RAD51: CAJ05032/
AAC16334. T.brucei DMC1: XP_827266/ EAN76936.
T.cruzi DMC1: XP_821533/XP_818873. L.major DMC1:
AAZ14711/AAC16335. T.brucei RAD51-3: XP_828338.
T.cruzi RAD51-3: XP_820915. L.major RAD51-3:
CAJ06683. T.brucei RAD51-4: XP_828775. T.cruzi
RAD51-4: XP_807204/XP_809595. L.major RAD51-4:
CAJ02433. T.brucei RAD51-5: EAN78580. T.cruzi RAD51-
5: XP_811996/XP_807606. T.brucei RAD51-6: AAX81032.
T.cruzi RAD51-6: XP_806422. L.major RAD51-6:
AAZ09495.
RESULTS
Trypanosoma brucei encodes six RAD51-related proteins
The largely complete genome sequence of T.brucei and two
related trypanosomatid parasites (T.cruzi and L.major) has
been determined recently. From these sequences (88), six sin-
gle copy RAD51-related genes could be identified in both
T.brucei (Figure 1) and T.cruzi (Table 1), and five in
L.major (data not shown). One gene, described previously
(31), encodes RAD51 itself; the predicted amino acid
sequence of this is highly conserved with other eukaryotes
(60–80% sequence identity), and homologues have been
Figure 1. A comparison of RAD51-related proteins in T.brucei. T.brucei RAD51 amino acid sequence (top) is compared with the T.brucei RAD51-like predicted
polypeptides; the alignment was carried out using ClustalW (111), manually adjusted and coloured using Boxshade 3.21 (residues identical in 30% or more sequences
are boxed black, conserved residues are boxed grey). Walker A (A) and B (B) boxes conserved in all the proteins are indicated, as are a putative polymerization motif
(PM), a helix–hairpin–helix motif (H–h–H) and catalytic and structurally conserved residues (closed circles) in RAD51 and DMC1.
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shown to be transcriptionally induced by DNA damage in
L.major (89) and Plasmodium falciparum (90). Another
gene is highly related to T.brucei RAD51 (49% sequence
identity; Figure 1) but groups closely with Dmc1 from
other eukaryotes in phylogenetic analysis (data not shown).
All the other genes are more distantly related to RAD51 (10–
17% sequence identity with T.brucei RAD51). Sequence
alignments show the relationship between these proteins,
RAD51 and DMC1. The central core of all the proteins,
which is conserved between eukaryotic Rad51 and eubacterial
RecA (91), contains Walker A and B box nucleotide binding
motifs. In contrast, further residues that are known to be
important for the structure and enzymatic activity of Rad51
and RecA (92) are not well conserved beyond T.brucei RAD51
and DMC1. Outside the RecA-related core, a helix–hairpin–
helix motif involved in DNA binding (93,94) and a short motif
for polymerization of RAD51 in the nucleoprotein filament
(94,95) have been described: both could be identified in
T.brucei RAD51 and probably also in DMC1, but were not
apparent in the four other polypeptides. Attempting to assign
functional identities to the diverged T.brucei predicted pro-
teins based on this analysis, or on pairwise sequence compar-
isons with RAD51-like proteins from other eukaryotes
(Table 1), or by phylogenetic analysis (data not shown), is
difficult and so we have given the genes systematic names.
Nevertheless, comparison of the predicted T.brucei proteins
with those in T.cruzi (Table 1) identifies clear orthologues,
showing that the functions of these factors are conserved in at
least these two kinetoplastids.
T.brucei RAD51-3 and RAD51-5 are involved in
DNA repair and recombination
To examine the roles of the divergent RAD51-like genes in
T.brucei, we made mutants of RAD51-3, which is marginally
the most related gene to T.brucei RAD51 (17% amino acid
sequence identity), and RAD51-5, the most distantly related
(10% identity). In each case, the central core of the ORF
(including the Walker A and B boxes) was replaced with
antibiotic resistance cassettes. Following transformation of
such constructs, homologous recombination using the 50 and
30 ends of the ORF allowed recombination into the T.brucei
genome, disrupting the endogenous alleles (Figure 2A) in a
similar manner to RAD51 mutants we generated previously
(31). Using two rounds of transformation we isolated hetero-
zygous (+/) and homozygous (/) mutants for both
RAD51-3 and RAD51-5 in bloodstream form cells of T.brucei
line 3174.2 (86). Southern analysis demonstrated that the allele
disruptions had occurred as predicted (Figure 2B and C), and
the absence of intact RNA transcripts in the / mutants was
confirmed by RT–PCR (Figure 2D).
Although the rad51-3/ and rad51-5/mutants are viable,
each displayed an increased population doubling time
in vitro relative to wild-type cells or their +/ antecedents
(Figure 3). Wild-type population numbers doubled on average
in 8.2 (±0.4) h, compared with 8.55 (±0.15) h and 7.8 (±0.2) h
for the RAD51-3+/ and RAD51-5+/ cells, respectively. In
contrast, rad51-3/ mutants doubled in 15.35 (±0.35) h,
and rad51-5/ mutants in 12.7 (±0.1) h. This level of growth
impairment is at least comparable with, and may even be more
severe than, that of T.brucei rad51/ mutants (31). It is pos-
sible in kinetoplastids to define the cell cycle stage of indi-
vidual cells by DNA staining following fixation (96). By doing
this, we found that the increased population doubling time of
the rad51-3/, rad51-5/ or rad51/ cells was not due to
accumulation of cells at a single cell cycle stage (data not
shown), and perhaps represents higher levels of cell death
in the mutants. Despite their in vitro growth impairment,
the rad51-3/ and rad51-5/ mutants were still able to
establish infections in rodent hosts, as do rad51/ mutants
(31), with increased population doubling times relative to
wild-type or +/ cells still apparent (data not shown).
To determine whether or not RAD51-3 and RAD51-5 con-
tribute to DNA repair in T.brucei, we next assayed the ability
of the mutants to grow from single cells at various concen-
trations of MMS (Figure 4). The results for either gene were
very similar: disruption of a single allele caused no increased
sensitivity to MMS relative to wild-type cells, whereas dis-
ruption of both alleles caused a markedly increased sensitivity
to MMS. The level of this phenotype is comparable with that
described previously for rad51/ mutants (35), and indicates
that both proteins contribute to the repair of MMS-induced
DNA damage. Indeed, both the / mutants display increased
sensitivity to phleomycin also (data not shown), indicating a
general repair deficiency.
To date, Rad51 paralogues have been shown to influence the
efficiency and profile of mitotic homologous recombination
only in yeast and vertebrates. To test this in T.brucei, we
compared the efficiency with which the rad51-3/ and
rad51-5/ mutants generate antibiotic resistant transformants
following electroporation relative to wild-type and +/ cells.
To do this, we transformed all the cell lines with the construct
tub-BLE-tub, which encodes the bleomycin resistance protein
and normally should confer phleomycin resistance after integ-
rating in the tubulin locus via homologous recombination on
terminal sequences derived from a- and b-tubulin intergenic
equences (35). In a number of previous studies we have shown
that the number of transformants generated by electroporation
Table 1. Percent amino acid sequence identities comparing RAD51-like proteins from T.brucei and T.cruzi, and from T.brucei and Homo sapiens
T.cruzi H.sapiens
T.brucei RAD51 DMC1 RAD51-3 RAD51-4 RAD51-5 RAD51-6 RAD51 DMC1 XRCC2 XRCC3 RAD51B RAD51C RAD51D
RAD51 79.9 48.5 18.1 17.1 12.8 16.7 60.1 44.8 14.3 20.3 20.2 19.5 16.2
DMC1 48.2 88.0 18.5 15.9 11.7 15.9 52.7 57.3 14.6 20.7 23.8 19.7 14.8
RAD51-3 16.1 17.1 49.8 14.6 12.5 12.7 17.7 18.3 12.4 16.3 17.0 22.8 10.8
RAD51-4 14.6 18.2 14.3 39.9 15.6 13.3 15.5 15.1 10.9 17.4 15.8 15.7 16.4
RAD51-5 11.4 12.1 12.4 12.4 34.8 13.8 11.8 13.6 12.3 15.1 13.1 11.9 15.4
RAD51-6 15.3 17.2 16.4 13.8 17.1 39.2 16.8 15.3 8.0 17.0 14.9 15.6 11.7
Likely orthologous proteins are indicated by grey shading.
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of this and other constructs is a reliable measure of recomb-
ination efficiency in T.brucei, where non-homologous
recombination has never been observed (33,34,38,97). The
results of this analysis are shown in Figure 5, and demonstrate
that the rad51-3/ and rad51-5/ mutations resulted
in impaired, though not abolished, recombination. The
rad51-3/ mutant cell lines showed between a 3.8- and 9-
fold reduction in transformation efficiency relative to their +/
antecedents or wild-type cells, whilst the two rad51-5/ cell
lines displayed 6.7- and 7.7-fold reductions. The extent of this
impairment appears not to be as severe as that observed in
rad51/ mutants, where a 7- to 16-fold reduction in recomb-
ination efficiency was observed for a range of constructs (34),
but is more severe than we observed for mre11/ mutants
(35). Since transformants were still detected in the /
mutants, we examined the patterns of plasmid integration
by Southern analysis. In T.brucei rad51/ mutants most
integrations occur by homologous recombination, but small
numbers of microhomology-dependent reactions can also be
found (34). In all cases in the rad51-3/ and rad51-5/
mutants, however, plasmid integrations had occurred by
homologous recombination (data not shown), and no
microhomology-dependent reactions were observed.
Mutation of RAD51-3 or RAD51-5 attenuates the ability
of T.brucei to form DNA damage-induced RAD51
sub-nuclear foci
If T.brucei RAD51-3 and RAD51-5 are functionally equival-
ent to the Rad51 paralogues in other organisms, at least a
component of their cellular functions should be to contribute
to RAD51-mediated recombination. To test this, we examined
RAD51 localization in the rad51-3/ and rad51-5/
mutants relative to wild-type and +/ T.brucei before and
Figure 2. Generation of RAD51-3 and RAD51-5 mutants in bloodstream form T.brucei. (A) For both genes, the central core of the ORF, containing the Walker (A)
and (B) boxes (black) was deleted (open triangle) by and replaced with cassettes encoding either blasticidin (RAD51-3::BSD/RAD51-5::BSD) or puromycin
resistance (RAD51-3::PUR/RAD51-5::PUR). (B and C) Southern blots of wild-type (WT), two heterozygous mutants (+/ 1, 2) and two homozygous mutants (/
1, 2) probed with the ORFs of RAD51-3 or RAD51-5. RAD51-3 mutants’ genomic DNA was digested with BstXI, while SpeI was used for RAD51-5 mutants. Positions
of size markers (in kb) are indicated, and hybridizing fragments from the WT genes, prior to disruption, or the disrupted alleles are marked by arrow heads. (D) RT–
PCR on cDNA from WT, +/ or/ cells using primers specific for RAD51-3 or RAD51-5; RNA Pol I-specific primers were used to demonstrate intact cDNA was
present.
Figure 3. Growth of RAD51-3 and RAD51-5 mutants in vitro. Growth of wild-
type (WT), two heterozygous mutants (+/ 1, 2) and two homozygous mutants
(/ 1, 2) of RAD51-3 and RAD51-5 were compared by measuring cell den-
sities at the given times. Growth of rad51-3/ and rad51-5/ cell lines in
which an intact copy of the mutated gene was re-expressed from the tubulin
locus (//+) is shown also.
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after induced DNA damage. In yeast and vertebrates, many
forms of DNA damage have been shown to cause a
re-localization of Rad51 into sub-nuclear foci. The formation
of such foci is believed to be a component of eukaryotic cells’
response to DNA damage, and they are thought to represent a
site of repair in which many factors co-localize [for reviews
see (45,98)]. Moreover, the formation of RAD51 foci is
dependent on a range of factors, including the Rad51 para-
logues (62,65,66).
To assess the localization of T.brucei RAD51 following
DNA damage, immunolocalization was conducted using anti-
serum recognizing T.brucei RAD51 on methanol-fixed blood-
stream form cells that had been exposed to phleomycin, which
causes DSBs (99). A full discussion of this analysis will
be published elsewhere (K. Norrby, C. Proudfoot and R.
McCulloch, manuscript in preparation), but Table 2 shows
the percentage of cells displaying foci and the number of
foci detectable in individual cells, while Figure 6 shows
examples of such foci. In RAD51-3+/, RAD51-5+/ and
wild-type cells, discrete sub-nuclear RAD51 loci could readily
be detected following phleomycin treatment. At this concen-
tration of drug (1.5 mg ml1), a majority of wild-type and +/
cells displayed foci (only 22–35% showed no foci), whereas in
the absence of phleomycin only 1% of cells showed any sub-
nuclear localization of RAD51 (data not shown). Most cells
contained between 1 and 3 RAD51 foci, although small num-
bers of cells containing larger numbers were detectable. No
difference in the proportion of cells containing foci was dis-
cernible between the wild-type and RAD51-3+/ or RAD51-
5+/ cells. In contrast, the formation of RAD51 foci was
attenuated in both the rad51-3/ and rad51-5/ mutants.
For the / mutants, RAD51 localization was examined at an
Figure 4. RAD51-3 or RAD51-5 mutation leads to DNA damage sensitivity. The survival of wild-type (WT) T.brucei in the presence of increasing concentrations of
MMS was compared with heterozygous (+/) and homozygous (/) mutants of both RAD51-3 and RAD51-5 by plating each cell line at one cell well1 in 96-well
plates. The average number of wells containing growing parasite populations after 7–20 days is plotted as a percentage compared with the average number of wells
surviving in the absence of MMS. SD is indicated and the data are presented for two (1 and 2) independent heterozygous and homozygous mutants for each gene.
Figure 5. RAD51-3 or RAD51-5 mutation impairs recombination. The number of transformants recovered (per 106 cells put on antibiotic selection) when the
construct tub-BLE-tub was electroporated into wild-type (WT) T.brucei, or into two independent heterozygous (+/ 1, 2) or homozygous (/ 1, 2) mutants of
RAD51-3 or RAD51-5, is shown. Values are averages from three experiments, and SDs are indicated.
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equivalent phleomycin concentration to the wild-type and +/
cells and also at reduced concentrations. This was done
because the mutants are more sensitive to phleomycin-
induced damage, and we have found that at high concentra-
tions (>5 mg ml1), RAD51 foci are undetectable in wild-type
cells, possibly because the cells are severely compromised
(data not shown). Phleomycin (0.3 and 0.5 mg ml1) was
used for the rad51-3/ and rad51-5/ mutants, respectively,
because these levels caused comparable levels of cell death or
growth retardation relative to wild-type and +/ cells grown in
1.5 mg ml1 phleomycin (data not shown). Irrespective of the
drug concentration used, in both / mutants a majority of
cells (52–82%) did not have RAD51 foci and, where foci were
detected, this was rarely more than one or two (Table 2). In
fact, this may be an overestimate, since for both / mutants,
but particularly rad51-5/, higher levels of cytoplasmic
staining were apparent following phleomycin treatment, and
some staining may have been counted as foci.
RAD51-3 contributes to T.brucei antigenic
variation, but RAD51-5 does not
To examine the roles of RAD51-3 and RAD51-5 in T.brucei
VSG switching, the mutants were made in the strain 3174. We
have described this strain before (31,33,35,38,86). Briefly, it
expresses genes encoding resistance to G418 and hygromycin
from the active ES (encoding VSG221) and allows the
frequency of VSG switching to be calculated using an
in vivo selection regime, which also generates clonal switched
variants in which the type of switching event used can be
assessed via the antibiotic resistance genes. Figure 7 shows
the VSG switching frequencies determined for mutants of the
two RAD51-like genes relative to wild-type cells, while
Figure 8 shows the profiles of VSG switching events that
the cell lines employ. In doing this analysis, we re-
introduced intact copies of the RAD51-3 or RAD51-5 genes
into one of the two independently generated rad51-3/ or
rad51-5/ mutants, respectively. In each case, re-expression
reverted the strong growth impairment that we observed, res-
ulting in population doubling times in the two re-expression
cell lines that were indistinguishable from wild-type or +/
cells (Figure 3).
As we have observed before, there was considerable vari-
ation in the VSG switching frequencies determined by this
assay, reflecting the randomness of the process and the low
Table 2. Percentages of RAD51-3 or RAD51-5 mutant cells displaying RAD51
foci following 18 h growth in phleomycin (BLE; concentrations are in
mg ml1), and the number of foci that are visible
[BLE] No. of foci
0 1 2 3 4 5 6 L
RAD51-3
Wild type 1.5 35.0 28.2 21.4 10.3 3.4 3.4 0.9 0.9
1+/ 1.5 27.4 30.8 18.8 15.4 6.0 1.7 0.0 0.0
1/ 0.3 81.7 7.3 5.5 5.5 0.0 0.0 0.0 0.0
1/ 1.5 63.8 18.1 12.1 3.4 2.6 0.0 0.0 0.0
2+/ 1.5 22.2 26.5 18.8 14.5 4.3 1.7 0.9 1.7
2/ 0.3 59.0 19.7 12.0 4.3 0.9 0.9 0.0 0.0
2/ 1.5 52.1 24.8 8.5 0.9 1.7 0.9 0.0 0.9
RAD51-5
Wild type 1.5 22.3 16.1 24.1 17.9 11.6 4.5 1.8 1.8
1+/ 1.5 19.8 24.3 33.3 14.4 5.4 1.8 0.9 0.0
1/ 0.5 67.3 18.3 16.3 5.8 1.0 0.0 0.0 0.0
1/ 1.5 59.5 18.0 9.0 2.7 0.9 0.9 0.0 0.9
2+/ 1.5 27.9 32.4 19.8 13.5 2.7 4.5 3.6 3.6
2/ 0.5 64.0 22.5 7.2 3.6 0.9 0.0 0.9 0.9
2/ 1.5 64.9 23.4 3.6 1.8 2.7 0.0 0.0 0.0
L represents >6 foci, +/ denotes heterozygous mutants, and / denotes
homozygous mutants).
Figure 6. Examples of RAD51 foci in T.brucei. Examples of RAD51-3 or RAD51-5 heterozygous (+/) or homozygous (/) mutants with discernible sub-nuclear
RAD51 foci following 18 h growth in 1.5mg ml1 phleomycin are shown. Cells were visualized by differential interference contrast (DIC; left), the DNA was stained
with DAPI (centre left), and RAD51 (centre right) was visualized using a polyclonal anti-RAD51 antiserum and FITC conjugated goat-derived anti-rabbit IgG
secondary. Merged DAPI and RAD51 images are also shown (right).
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rate (2–11 · 107 switchers cell1 generation1) at which
VSG switch variants arise in the Lister 427 strain from which
3174 wild-type cells are derived (31,33,35,38,86). However, it
was apparent that disruption of RAD51-3 led to a reduction in
VSG switching frequency in each of the two independently
generated rad51-3/ mutants. The average switch frequen-
cies for the mutants were 0.5 · 107 and 1.5 · 107 switches
cell1 generation1, which represents statistically significant
reductions (Figure 7) relative to either the +/ cells from
which they are derived (average switch frequencies, 6.1 and
7.0 · 107, respectively), the wild-type cells (8.1 · 107) or
the RAD51-3 re-expressor (3.6 · 107). In fact, the calculated
switch frequencies for the rad51-3/ mutants may be over-
estimates, as we consistently failed to recover any switched
variants in some of these experiments (3 out of 8 repetitions for
rad51-3/1, and 3 out of 6 for rad51-3/2; negative experi-
ments were excluded from the frequency calculations, how-
ever). This was not seen for any other cell lines, and suggests
that the switch frequency for these mutants may be at the
threshold of detection under the assay conditions we have
employed.
In contrast to RAD51-3, we found no evidence that RAD51-
5 contributes to VSG switching. The calculated VSG switch-
ing frequencies for the two rad51-5/ mutants (averages of
3.6 · 107 and 5.4 · 107 switches.cell1.generation1)
were not statistically significantly different from the wild-
type cells (P-values 0.50 and 0.89, respectively), or from
the +/ cells from which they were derived (Figure 7; aver-
ages of 1.9 · 107 and 2.8 · 107, respectively) or the RAD51-
5 re-expressor (1.8 · 107).
To determine whether or not disruption of either of the
RAD51-like genes alters the profile of VSG switching mech-
anisms in T.brucei, a number of variant clones from each of the
cell lines were assayed for the type of VSG switching event
that they had undergone. In this assay, we can distinguish three
types of switching event (Figure 8A). Firstly, transcriptional,
or in situ, switches are identified by retention of VSG221 and
the antibiotic resistance genes. Secondly, events in which
VSG221 and the antibiotic resistance genes are deleted rep-
resent either gene conversions that encompass all these
Figure 7. Effect of RAD51-3 or RAD51-5 mutation on the frequency of VSG
switching. VSG switching frequencies for wild-type T.brucei cells (3174.2;
WT) were compared with two independently generated heterozygous (+/ 1, 2)
and homozygous mutants (/ 1, 2) of either RAD51-3 or RAD51-5, in addition
to rad51-3/ and rad51-5/ cell lines in which an intact copy of the
mutated gene was re-expressed from the tubulin locus (//+). Means of at
least three independent experiments, plus SDs, are shown. P-values (deter-
mined by Student paired t-tests) of +/ cells’ VSG switching frequencies
relative to wt cells are indicated above the graph, as are the / cells’ fre-
quencies relative to the +/ cells from which they are derived, and the //+
cells relative to the / mutants.
Figure 8. Effect of RAD51-3 or RAD51-5 mutation on the VSG switching profile. (A) The form of VSG switching used in each cell line (see text) was determined by
assaying for the expression of hygromycin and G418 resistance from the antibiotic marker genes (HYG and NEO, respectively) inserted around VSG-associated 70 bp
repeat sequences (hatched box) in the active VSG221 ES (arrow denotes promoter) in strain 3174, as well as using PCR to assess whether HYG, NEO or VSG221 had
been removed by gene conversion. (B) The percentage of clones that had undergone VSG switching by in situ switching, ES gene conversion/deletion or VSG gene
conversion/deletion (see text) for each cell line are shown; the number of clones analysed (n) is indicated above the graph.
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markers (86), or deletions of these genes accompanied by
a switch in transcription to another ES (100) (we term these
ES gene conversion/deletions). Thirdly, events in which the
hygromycin resistance gene is retained and continues to
be expressed, but the G418 resistance and VSG221 genes
are deleted, most probably represent gene conversions of
the VSG that extend to the 70 bp repeats, although may rep-
resent deletions of the ES on the 70 bp repeats that elicit
a transcriptional switch to another ES (termed VSG gene
conversion/deletion). Very occasionally (3% of switch vari-
ants), we observed events that are not readily explained by
these switching reactions, and we termed these ‘unknown’.
Despite considerable fluctuation in the data (Figure 8B), in
general terms in the wild-type, RAD51-3+/, RAD51-5+/,
RAD51-3 re-expressor and RAD51-5 re-expressor cell lines
in situ switches slightly predominated (24–80% of switching
events) over ES gene conversion/deletions (10–66%), whilst
VSG gene conversion/deletions were relatively rare (0–20%).
In the homozygous mutants of each gene, all of the different
VSG switching events could be detected. Variations in the
proportion of the events in these mutants (for instance,
between rad51-3/ mutants 1 and 2; Figure 8B) most prob-
ably reflect fluctuations in sampling, rather than phenotypic
differences. This indicates that both transcription- and
recombination-based switching still occur. Indeed, the recom-
bination event seen most rarely (VSG gene conversion/
deletion) was still detected readily, indicating that recombina-
tion accounts for a significant proportion of VSG switching.
For the rad51-5/ mutants, this is not surprising, as no change
in VSG switch frequency was observed. For the rad51-3/
mutants, which had impaired VSG switching, this is reminis-
cent of what we observed previously for rad51/ mutants,
where no change in the ratio of transcription- and
recombination-based switching was found (31), and suggests
that the lowered VSG switching frequency in these mutants is
not due to a selective reduction in recombination-based
switching, as might be expected for proteins which act in
homologous recombination.
DISCUSSION
Work from vertebrates, plants, insects and fungi indicates that
eukaryotic organisms encode a complex repertoire of Rad51-
like proteins. Here, we add to that picture by showing that
T.brucei, a highly divergent eukaryote (10), encodes six
RAD51-related proteins. We show that two of the distantly
related T.brucei RAD51-like proteins, like RAD51 itself
(31,34), act in mitotic DNA repair and recombination. Fur-
thermore, both RAD51-like proteins contribute to the forma-
tion of RAD51 sub-nuclear foci following DNA damage. To
date, the formation of such foci has been observed in fungi
(101), vertebrates (45) and nematodes (102), and the finding
that it occurs also in T.brucei suggests that it is a widely
conserved eukaryotic response to DNA damage (98).
Although Rad51 and Dmc1, a meiosis-specific homologue
of Rad51 (43), are highly conserved between eukaryotes, fur-
ther Rad51-like proteins are highly diverged. This is apparent
in the low levels of sequence identity amongst the proteins,
and also differences in the numbers of such proteins encoded
by eukaryote genomes. Most metazoans appear to encode
relatively large families of diverged Rad51-like proteins:
vertebrates (44,45) and Arabidopsis (49) contain five,
whilst Drosophila (50) contains four. In contrast, fungi
appear to encode a smaller repertoire (103) with one, two
and three diverged Rad51-like proteins described in U.maydis,
S.cerevisiae and S.pombe, respectively. The presence of four
distantly related RAD51-like genes in T.brucei and T.cruzi is
more reminiscent of metazoan organisms, and illustrates that
the number of such genes an organism possesses cannot sim-
ply be related to genome size or multicellularity. Indeed, this is
strikingly demonstrated by the fact that Caenorhabditis
elegans encodes only Rad51, and no Rad51-like proteins
(104). By understanding the similarities and differences in
the roles of these proteins in different organisms, and their
interactions with each other and with other recombination
factors, including Rad51, we will understand the complex
evolutionary history of the recombination machinery in euka-
ryotes. For example, it remains unclear whether or not the
diverged Rad51-like proteins (and protein complexes) are
truly paralogues (44), as they are often referred to. Moreover,
it is unknown if they provide essentially the same functions in
different organisms, or if their roles (and presence or absence)
are tailored to the unique biology of each organism.
Distinct functions for RAD51-3 and RAD51-5 in
T.brucei antigenic variation
A critical function of DNA recombination in T.brucei is in the
switching of VSGs during antigenic variation. We have shown
previously that this process is influenced by RAD51 (31), and
now demonstrate that a RAD51-like protein, RAD51-3, has a
similar role. This provides further evidence that at least some
VSG switching is driven not by a recombination machinery
dedicated specifically towards antigenic variation, but by gen-
eral homologous recombination proteins that act in ‘house-
keeping’ repair. An orthologue of RAD51-3 (and, indeed, of
each T.brucei RAD51-like protein) could be identified in
T.cruzi, demonstrating that this factor has not evolved for
VSG switching.
We show also here that a second RAD51-like protein,
RAD51-5, does not detectably contribute to T.brucei antigenic
variation. It is possible that this phenotype is explained by
genetic redundancy, where one of the other RAD51-like
proteins can assume RAD51-5’s function when it is absent.
Indeed, it is notable that RAD51-5 appears not to be present in
L.major, a related kinetoplastid parasite. Alternatively, it may
be that RAD51-3 has a more central function in homologous
recombination than RAD51-5, and any effect on VSG switch-
ing caused by mutating RAD51-5 is too subtle to be detected
by our assay. However, rad51-3/ and rad51-5/ mutants
both displayed very similar levels of impairment in DNA
repair, recombination of transformed DNA constructs and
RAD51 foci formation, indicating that either of the above
explanations extend only to homologous recombination during
VSG switching. We favour a third explanation, that the
distinction between rad51-3 and rad51-5 mutants in VSG
switching indicates that the proteins have distinct roles in
homologous recombination. None of our analysis to date
allows us to say if RAD51-3 and RAD51-5 operate in the
same pathway in the cell, or if they interact. However,
unlike in S.cerevisiae, where Rad55 and Rad57 form a stable
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heterodimer that acts as a single co-factor in Rad51-catalysed
recombination (46), considerable evidence from metazoans
points to functional diversification of the Rad51 paralogues.
In mammals, Xrcc3 has been shown to localize to DSBs prior
to, and independently from, Rad51, suggesting that it may
prepare breaks for RAD51 binding (78). Furthermore, mam-
malian Rad51D, but not Rad51C or Xrcc2, interacts with
telomeres and mutation leads to telomere dysfunction, sug-
gesting that it can act in telomere maintenance (81). Rad51C
and Xrcc3 have been shown to be involved in Holliday junc-
tion processing in human cell extracts (80), suggesting a late
role in homologous recombination, which is consistent with
altered profiles of homologous recombination reactions
observed in Xrcc3 mutant hamster cells (79). Finally, specific
roles of a sub-set of the diverged Rad51-like proteins may be
seen also during meiotic recombination in plants and yeast
(49,84,85). If we are correct for T.brucei, then this functional
diversification is common to many eukaryotes, not just to
some metazoans.
In T.brucei we still know very little about the detailed bio-
chemistry of the recombination reactions that drive VSG
switching, and therefore a number of scenarios might be envis-
aged to explain the distinction in functions between RAD51-3
and RAD51-5. For example, we do not know the nature of the
event(s) that initiates VSG switching. It has been suggested
that this is most probably a DSB (105,106), and an endonuc-
lease to generate this lesion has been postulated (106). How-
ever, perhaps RAD51-5 acts at an early step in recombination
by binding DSBs, and VSG switching is initiated by a distinct
DNA lesion and thus bypasses the need for RAD51-5. Such
a scenario may also explain the lack of a role for T.brucei
MRE11 (35): the initiating lesion may not require MRE11 to
contribute to processing the DNA ends (107), or may not
activate the DNA damage signalling functions that have
been ascribed to this protein in other organisms (108). An
alternative scenario is that RAD51-5 is a component of the
T.brucei counterpart of the human Rad51C–Xrcc3 complex,
which contributes to Holliday junction resolution (80). It has
been pointed out before that it would be advantageous for VSG
switching to proceed by a synthesis-dependent strand anneal-
ing mechanism, as this would avoid the formation of Holliday
junction intermediates that could lead to lethal translocations
of silent VSG arrays into the ES (11,105,106). Finally, we
might also envisage that RAD51-3 has a predominantly (sub)
telomeric function, akin to human Rad51D (81), and perhaps
directs T.brucei DSB repair in this environment, while
RAD51-5 acts in interstitial repair. The sub-telomeres of
T.brucei, in common with many pathogens (9), are where
antigenic variation is conducted: VSGs are transcribed at
the ends of the ESs, recombination must occur here for
VSG switching and, it is now clear, the large majority of
the silent VSG archive is sub-telomeric (22).
Does transcriptional VSG switching involve
recombination?
A striking finding from this work is that the VSG switching
phenotype we described previously in T.brucei rad51/
mutants (31) is re-capitulated in rad51-3/ mutants: the
impairment in VSG switching is of a similar magnitude,
and there is no compelling evidence that this impairment arises
owing to a selective reduction in recombination-based VSG
switching over transcription-based switching. Given that
rad51-5/ and mre11/ mutants (35) do not cause a reduc-
tion in VSG switching frequency, but have similar levels of
growth impairment to rad51/ and rad51-3/ cells both
in vitro and in vivo, the VSG switching phenotype cannot
be explained as a growth artefact. As we have argued before
for RAD51 (31), this genetic implication of RAD51-3 in tran-
scriptional switching does not necessarily infer a direct cata-
lytic role for recombination, but offers independent evidence
that recombination factors may contribute to the process.
Much of the work to date on VSG transcriptional switching
has focused on the mechanisms that limit full transcription to 1
of the 20 or so ESs (20), rather than the switching process
itself. Transcriptional switching appears to be a co-ordinated
reaction, since Borst and co-workers (19) have identified
putative switching intermediates in which two ES are co-
transcribed unstably and switch to expressing one or other
ES at very high rates. It is intriguing that this intermediate
can involve two ESs but not three (109), and that the two ESs
are found rather close together in the nucleus. Furthermore,
treatments that cause nuclear DNA damage or replication
arrest result in increased transcription from the silent ESs,
as well as other silent loci (109,110). These data are not
incompatible with RAD51 and RAD51-3 contributing to the
reaction, although it is unlikely to be this simple. For instance,
transcriptional (and recombination) switching events could
still be detected in the rad51 and rad51-3 mutants, suggesting
(at the very least) that other factors must be able to assume
their functions. Moreover, some of the DNA damage which
causes altered ES expression (e.g. alkylation or interstrand
cross-links) is most probably recognized and repaired by
DNA repair pathways other than homologous recombination.
Nevertheless, RAD51 and RAD51-3 are the only genes to date
whose mutation has been shown to have any effect on VSG
switching, and it is possible that the regulation and execution
of antigenic variation has links with cellular repair pathways
that we are only beginning to understand.
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